Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
IDP:FRA
Biogen Inc
160,46 €
-1,27%
(-2,06) 1D
30 აპრ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IDP...
Open
165,62 €
High
165,62 €
Low
160,46 €
Mkt. cap
27,62 მლრდ.
Avg. vol.
23,00
Volume
6,00
52-wk high
169,30 €
52-wk low
102,65 €
No. of employees
8 ათ.
News stories
From sources across the web
Profile
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs. The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
About Biogen Inc
CEOქრის ვიბახერ
Employees7,5 ათ.
Founded1978
Headquartersკემბრიჯი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websitebiogen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
2,65 მლრდ.
2,53 მლრდ.
2,28 მლრდ.
2,48 მლრდ.
Cost of goods sold
946,20 მლნ.
508,60 მლნ.
443,40 მლნ.
610,20 მლნ.
Cost of revenue
946,20 მლნ.
508,60 მლნ.
443,40 მლნ.
610,20 მლნ.
Research and development expenses
-
431,80 მლნ.
501,00 მლნ.
482,20 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
581,30 მლნ.
592,80 მლნ.
685,20 მლნ.
607,30 მლნ.
Operating expense
783,70 მლნ.
1,25 მლრდ.
1,39 მლრდ.
1,30 მლრდ.
Total operating expenses
1,73 მლრდ.
1,76 მლრდ.
1,83 მლრდ.
1,91 მლრდ.
Operating income
915,60 მლნ.
778,60 მლნ.
447,70 მლნ.
567,40 მლნ.
Other non operating income
-3,30 მლნ.
15,80 მლნ.
17,40 მლნ.
-1,10 მლნ.
EBT including unusual items
744,00 მლნ.
557,30 მლნ.
-56,00 მლნ.
377,70 მლნ.
EBT excluding unusual items
861,60 მლნ.
748,30 მლნ.
423,10 მლნ.
530,10 მლნ.
Income tax expense
109,20 მლნ.
90,80 მლნ.
-7,10 მლნ.
58,20 მლნ.
Effective tax rate
14,68%
16,29%
12,68%
15,41%
Other operating expenses
75,00 მლნ.
87,20 მლნ.
69,90 მლნ.
74,20 მლნ.
Net income
634,80 მლნ.
466,50 მლნ.
-48,90 მლნ.
319,50 მლნ.
Net profit margin
24,00%
18,40%
-2,15%
12,89%
Earnings per share
5,47
4,81
1,99
3,57
Interest and investment income
32,30 მლნ.
31,60 მლნ.
37,20 მლნ.
37,90 მლნ.
Interest expense
-72,60 მლნ.
-67,40 მლნ.
-67,50 მლნ.
-67,60 მლნ.
Net interest expenses
-40,30 მლნ.
-35,80 მლნ.
-30,30 მლნ.
-29,70 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,11 მლრდ.
980,80 მლნ.
647,90 მლნ.
771,80 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer